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Abstract 
 
The total amount of waste drugs is expanding 
significantly as populations age and societies become 
wealthier. Drug waste is becoming a problem for 
health and environment. Thus, how to reduce and 
effectively dispose of waste drugs is increasingly 
becoming an issue for society. In this paper, we 
analyze the current situation with regard to existing 
systems for expired drug recycling and disposal in 
China and suggest that by connecting the involved 
practices of waste drug recycling, medication 
management, and household drug management the 
incentives to participate in an integrated drug 
recycling system can be dramatically increased for all 
involved actors. This is important from an IS 
perspective because such connecting of practices could 
account for a novel mechanism of information 
infrastructure emergence, known from physics as ‘state 
transition’. By contrast, the current literature focuses 
on the development of information infrastructures 
through growth at the periphery, mostly driven by user 
activity and enabled by modular and flexible designs. 
Our approach could explain the de-novo emergence of 
an information infrastructure. 
 
1. Introduction  
 
Household waste medicines refers to medicine 
waste residing within homes [1]. Such waste does not 
only cause economic loss but has also an adverse 
impact on the environment and on human health if the 
waste is improperly disposed of [2]. Specifically, 
medical substances have been detected in sewage 
effluents [3, 4], surface water [5], groundwater, and 
even drinking water [6]. Safety is also compromised 
when medicines fall into the hands of children or of 
individuals who wish to abuse the medicines 
themselves or to sell expired medicines on a “grey” 
market. 
In China, storing drugs for emergent use in homes 
in large quantities and varieties has become a common 
practice. With the rapid economic and social 
development of society the total amount of household 
waste drugs is expanding significantly. In 2014, a 
survey showed that about 78.6% of families in China 
have the habit of storing prescription medicine and 
more than 80% of the families do not regularly purge 
their stock from expired medicines and even fewer 
people know how to properly dispose of the expired 
medicine [7]. The survey also showed that 72.5% of 
families throw expired drugs into regular household 
waste, 5% flush them down the toilet or drain, and 6% 
of families even continue to use them. Therefore, how 
to dispose of expired drugs has become an important 
issue for government and society. However, systems 
and processes for recycling expired drugs are still in an 
early stage in China. Although the government and 
some enterprises have implemented such processes and 
systems, most of these activities are carried out by 
public welfare organizations with government playing 
only a promoting and guiding role, which tends to be 
ineffective with regard to coordinating various 
stakeholders and to be limited in duration and range. In 
the current recycling regime, there are no obligations 
or incentives for enterprises to collect and for 
consumers to return expired drugs. Thus, it is urgent to 
ask how to effectively reduce and dispose of expired 
drugs through better coordination among the various 
actors involved in drug-related activities.  
The accumulation of expired drugs in family homes 
is the result of a number of factors encompassing: (1) 
patients recovering before their dispensed medicines 
have all been taken; (2) therapies being stopped or 
changed because of ineffectiveness and/or unwanted 
side effects; (3) patients’ deaths; (4) factors relating to 
repeat prescribing and dispensing processes [8].  
Pharmaceuticals are special and therefore cannot be 
treated like other commodities [9]. Reasons for the 
special character of drugs include the high cost and 
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 long duration of research and development and the 
repercussions of the product not being available. This 
special character of drugs has implications for how to 
properly deal with expired drugs. On the one hand, 
expired drugs, when remaining unopened in their 
original container, would be expected to remain stable 
for an average of 57 months after their expiration [10]. 
An extreme case concerns Phenytoin (Dilantin), an 
anti-seizure medication, which remains effective for 20 
years following its expiration. On the other hand, some 
drugs, such as antibiotics, blood thinners, and 
chemotherapy drugs can become toxic and hazardous 
to human health and the environment if they are not 
disposed of properly [11]. Thus, effective practices to 
reduce drug waste include not only improving the use 
of drugs, but also the effective disposal of 
expired/unwanted drugs. In sum, it is urgent to reduce 
preventable medicine waste and to dispose effectively 
of inevitable medicine waste. This concerns the 
practices of drug logistics, drug household 
management, and medication management. These 
practices involve a large number of heterogeneous 
actors such as pharmaceutical manufacturers, 
wholesalers, retailers, logistics providers, general 
practitioners, community pharmacies, government, and 
consumers. These actors, together with their relations 
and interactions, constitute a complex socio-technical 
system. 
Recently, IS researchers have described such 
dynamic complex systems as information 
infrastructures (IIs) by defining IIs as shared, open 
(and unbounded), heterogeneous and evolving socio-
technical systems [12]. However, there is very little 
research on how to connect practices which, so far, are 
entirely unrelated to one another. The literature focuses 
on cases where an information infrastructure grows 
gradually through extension ‘at the edges’ driven by 
user communities and enabled by modular and flexible 
designs (ibid.). However, information infrastructures 
may also develop in a more discontinuous, 
‘punctuated’ manner [13]. This suggests that an 
information infrastructure may also emerge when three 
or more practices become related to one another which, 
so far, were unrelated. Drawing on a physics metaphor, 
the bringing together of several, so far unrelated 
practices may be sufficient to create a ‘boiling point’ 
where matter changes from one aggregate state to 
another. In this paper we therefore explore the 
facilitators and inhibitors of bringing together the three 
practices of waste drug recycling, medication 
management, and household drug management in order 
to understand the conditions under which the 
development of an information infrastructure, 
understood as an emergent phenomenon triggered by a 
re-configuration of practices, can happen. 
We begin by presenting the literature on waste drug 
recycling, medication management and household drug 
management and also briefly summarize the literature 
on information infrastructure development. Next, we 
describe and analyze the current situation of drug 
waste management in China and outline the barriers to 
extending and broadening these practices and systems. 
The fourth section explores the possibilities and 
problems of connecting the three practices concerned: 
waste drug recycling, medication management, and 
household drugs management. We argue that by 
connecting the three practices the preconditions for the 
emergence of an innovative information infrastructure 
that supports expired drugs recycling can be created. 
 
2. Literature review  
 
2.1. Waste drug recycling and drug review/ 
management systems 
 
To protect the environment, reduce economic loss 
and increase the safety of drug use, several 
international organizations have produced guidance 
information on managing waste medicines and on drug 
and medication review procedures [14, 15]. Some 
researchers advocate that an effective and well-
designed household waste drug recycling system can 
reduce avoidable waste medicines and effectively 
disposes of inevitable waste [1]. Kongar, Haznedaroglu 
[16] proposed a radio frequency identification-based 
information technology infrastructure for reverse 
logistics of end-of-life drugs products. 
Although industries have various levels of 
involvement with waste drug recycling applications,  
such practices are regarded as difficult as they 
complicate the traditional forward-oriented medicine 
supply chain [17]. Recycling of waste medicines is 
challenging and difficult to implement because no 
commercial value can be recaptured from waste 
medicines. This causes hesitation and reluctance of the 
actors in the medicine supply chain  to implement 
recycling processes [18]. This is quite a significant 
finding because it, in turn, inhibits initiatives to invest 
in the recycling infrastructure and related information 
systems and limits the scope for collaboration among 
actors. However, recycling packing materials, reuse of 
good condition medicines, sorting and separating 
processes of returned medicines etc. have become 
feasible practices to create residual value. 
As a result of strict regulations and health and 
safety concerns, effective use and management of 
drugs have also become important for reducing 
avoidable waste, such as intervention and guidance in 
drug use, standardization of medicine package sizes, 
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 improving prescribing patterns, and storage 
management within household. With regard to waste 
drug management practices, the NHS (UK) in 2012 
launched an action plan to determine how best 
practices can be shared to improve the use of 
medicines and to address medicine waste within the 
NHS [15]. The report also shows how improvements in 
the use of drugs have become an important part in the 
recycling of waste drugs. 
With regard to research on medication reviews and 
management, in 2016 the Pharmaceutical Care 
Network Europe (PCNE) defined medication review as 
a structured evaluation of a patient’s medicines with 
the aim of optimizing medicine use and improving 
health outcomes [14].  This entails detecting drug 
related problems and recommending interventions with 
regard to treatment effectiveness and avoidance of 
adverse drug events.  
The main objective of drug management is to 
reduce financial expenditure, avoid waste, increase 
access, and ensure that drugs are properly used [19]. 
The so-called drug management cycle includes 
selection, procurement, storage and distribution, and 
use [20]. In the household context, drug management 
includes consumers’ selection, purchase, storage, use, 
and disposal of drugs. Among these, the last item is 
related to drug recycling and the others are related to 
the medication review.   
 
2.2. Information infrastructure development 
 
The literature on information infrastructure design 
and development is largely in agreement with Hanseth 
and Lyytinen [12] characterization of information 
infrastructure as an open, shared, heterogeneous, and 
evolving socio-technical system. On this view, the 
development of an information infrastructure is not 
merely a switch between an old and a new information 
infrastructure, but a gradual and step-wise transition. 
Information infrastructure evolution is seen as an 
incremental, emergent process from simpler to more 
complex forms. Various authors have emphasized 
different aspects, such as the importance of standards 
[21], of the installed base [22], of modularity [23], of 
the role of users as designers [24], the flexibility of 
information infrastructure [25, 26], the role of 
governance structures [27], and the role of materiality 
[28]. However, the early emphasis on practices, as is 
evident in the foundational paper by Star and Ruhleder 
[29] has been largely lost. A view of information 
infrastructure as a constellation of practices has been 
proposed in the literature [30, 31] but not yet been 
widely adopted. 
 
3. The current situation of household waste 
drugs recycling in China  
 
In China, the recycling of expired drugs is still in 
an early stage. Some enterprises and governments at 
the local level are actively exploring and practicing 
different drug recycling models. These recycling 
models can be divided into two categories depending 
on who is the responsible actor, a pharmaceutical 
manufacturer (see Figure 1) or government (see Figure 
2). 
 
 
Figure 1. Pharmaceutical enterprise-led 
recycling for household waste drugs 
 
 
 
Figure 2. Government-led recycling for 
household waste drugs 
 
A typical example of the pharmaceutical enterprise-
led recycling model concerns the system set up by 
Guangzhou Baiyunshan Pharmaceutical Holdings 
(GBPH). Since the launch of an activity called “family 
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 expired drugs collection” in 2003 GBPH has carried 
out the activity regularly every year. Over the last 15 
years, the company’s recycling activities have been 
continuously extended. These extensions concern: 
• the range of participating enterprises (from 
initially a single company to the whole group), 
• the scope of operations (from a single locality 
to more than 200 cities nationwide), 
• the number of participating drugstores (from 
initially five to more than 6000 pharmacies and 
community medical institutions), 
• the reach of the service (from the doctor’s 
waiting room to door-to-door visits for lonely 
elders in designated communities), 
• the areas covered (from urban to rural), 
• and the mode of recycling (from offline to 
online). 
With the increasing awareness of the risks posed by 
expired drugs, more and more local governments have 
launched household expired drugs recycling activities 
and have made remarkable achievements in the 
improvement of recycling systems and the construction 
of expired drug collection points. Local governments 
have used various community centers as collection 
points for expired drugs. These collection points not 
only collect waste medicines but also provide some 
health-related service. 
Despite such constant efforts there are still 
significant limitations concerning the existing models 
for recycling expired drugs. Table 1 shows the 
problems identified.  
 
Table1. Problems identified 
Stakeholder Problems identified 
Waste drug recycling 
enterprises 
Residual value is lacking 
Recycling costs are high 
Pharmacists and 
doctors 
Enthusiasm is low 
Consumers Collection points are 
limited 
Awareness is low  
Enthusiasm is low 
Trust is low  
Governments Supervision is difficult 
 
Firstly, there is no commercial value left in the 
current waste drug recycling system and the costs of 
recycling and disposal are very high; for example, 
GBPH invests tens of millions for its recycling activity 
every year [32]. Most of waste drugs have been 
collected in traditional ways and directly incinerated. 
This kind of model cannot recapture any value from 
returned drugs. Thus, there is only a very small number 
of large pharmaceutical companies carrying out 
recycling for a limited duration and with a limited 
range.  
Secondly, there is no motivation for pharmacists 
and doctors to get involved in recycling activities. In 
government-led models, although the government is 
trying to ask pharmacists and doctors to provide 
health-related services in some community centers, 
there is no effective compensation mechanism. The 
activities are only known as charity. 
Thirdly, consumers’ awareness of possibilities to 
recycle drugs is low, together with the lack of 
incentives and of information sharing, which reduces 
consumers’ willingness to contribute to drug recycling 
and their trust in recycling enterprises.  
Finally, the lack of a tracking system makes it 
difficult for government to supervise drug recycling, 
leading to increases in the number of counterfeit drugs 
and creating an opening for a “grey” market for 
expired drugs to emerge. This has a negative impact on 
the environment, the financial situation of 
manufacturers, and causes social and health problems. 
However, it seems that the current models offer 
some levers to improve this situation. In the 
manufacturer-led model, GBPH has begun to adopt an 
online model for recycling and is building consumers’ 
electronic health profiles for some special groups (e.g., 
the elderly) since 2015.  With the development of drug 
QR codes in China, possibilities for electronic 
management of expired drugs recycling and drug 
management are shaping up. Government is also trying 
to provide more health-related services in its own 
model. To improve consumers’ awareness for the 
environment and their health, various specialists (e.g., 
pharmacists, environmental experts) provide drug and 
environment-related knowledge and advice. Thus, 
medication management is showing its role in the 
waste drug recycling process. 
 However, these practices have so far failed to 
evolve into an effective system for expired drugs 
recycling because they are not yet connected to each 
other. Following the clues provided by our analysis so 
far, we formulate: 
Proposition 1. Effective practices for drug 
recycling require multi-actor involvement and cross-
practice collaboration among the involved actors.  
Considering the dynamic complexity involved in 
such an undertaking, we portray an evolutionary 
process from a single to a triple-practice system which 
could lead to the emergence of an information 
infrastructure that connects the practices of waste drug 
recycling, drug management, and medication 
management. 
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 4. Emergence of an information 
infrastructure resulting from connecting 
the three practices 
 
4.1. Information infrastructure as a constell-
ation of aligned practices 
 
As described above (see Section 2.2), information 
infrastructures are commonly defined as evolving 
complex systems consisting of heterogeneous technical 
and social components and as being characterized by 
an in principle unbounded functional scope and 
societal reach. However, information infrastructures 
continue to be understood as essentially socio-technical 
systems with some technical components at their core. 
By contrast, Star and Ruhleder [29] have argued for a 
practice-based understanding of information 
infrastructure, a proposal which has not yet been 
widely appropriated in the literature. For our purposes, 
however, a practice-based approach offers unique 
advantages as it allows for an understanding of an 
information infrastructure as a set or ‘constellation’ of 
aligned practices  [30, 31]. On such a view, an 
information infrastructure emerges or evolves through 
many small-scale changes in related practices so that 
relevant information can start to flow more easily 
across these practices. For example, in most practices 
the use of computers for information storage and 
processing is quite common. However, sharing such 
information across practices often encounters formal 
and informal barriers. A traditional information 
systems approach would call for the definition of clear 
interface specifications so that information can flow 
more efficiently between related systems. However, a 
practice-based approach opens up many more 
possibilities, not all of which are technical in nature. 
Oftentimes, miniscule adaptations in system settings, 
coding procedures or data maintenance operations may 
be all that is needed in order to improve the flow of 
information across practices. While such changes may 
appear as insignificant and trivial when taken 
individually, in sum they may have far reaching effects. 
Discovering such opportunities for adaptation, 
however, is not an easy task. Members of one practice 
may have to improve their awareness and 
understanding of how related practices operate and 
‘function’. Thus, a better mutual understanding of 
related practices may be the most important first step 
towards making the many small-scale changes that, 
together, lead to the evolution or emergence of an 
information infrastructure, understood as a 
constellation of aligned practices. In the following we 
are guided by this understanding of information 
infrastructure which takes as its point of departure not 
a technical system that needs to be connected with 
other technical systems but a practice that needs to be 
better aligned with related practices. 
 
4.2. Methodological approach 
 
Due to the growing need for coordination and 
collaboration among various actors, the process of 
information infrastructure evolution and emergence is 
characterized by a high degree of unpredictability. 
Gray and Hovav [33] have introduced the use of 
scenarios to the IS field to address such uncertainty. 
Specifically, they argue that scenarios provide a 
legitimate and practical “way of communicating about 
the future” (1999, p. 15). Scenarios are not to be 
confused with predictions; rather, they help managers 
and politicians to understand the assumptions and 
implications of various possible courses of actions and 
thus to prepare for the future without having to predict 
it (1999, p. 15). 
Identifying key drivers is crucial for creating a 
scenario space [33]. In the following, we will apply 
this insight to develop a plausible scenario for evolving 
an information infrastructure for recycling expired 
drugs based on the assumption that such evolution is 
driven by the possibilities that result from connecting 
the involved practices in multiple ways. We will 
develop this scenario in three steps by gradually 
extending the number of connections between the three 
practices. 
 
4.3. Single practice scenario  
 
The first scenario views the three practices of waste 
drug recycling, household drug management, and 
medication management as independent and 
unconnected, as shown in Figure 3. This represents the 
current situation. 
 
 
 
Figure 3.  Three independent practices 
 
4.3.1. Waste drug recycling. Waste drug recycling 
involves manufacturers, wholesalers, retailers, logistics 
providers, and consumers. The objective of the system 
is to recycle the expired drugs from consumers. Based 
on some experiences in some developed countries, 
returned drugs are special types of end-of life (EoL) or 
end-of-use (EoU) returns of consumer goods [34]. 
   Waste drug 
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 Some waste medicines, as EoU returns, still preserve 
functionality intact and are capable of being reused 
[35]. Package-related returns bring some residual value 
and create useful information which can influence the 
package sizes, shapes, materials used and so on. Drug 
recycling enterprises optimize the package design to 
protect products properly and allow consumers to use 
the product safely.  
Electronic order management is beneficial for 
logistics companies to optimize transportation, for 
manufacturers and wholesalers to obtain expired drug-
related data to guide pharmaceutical research, 
development, design, and sales.  
Retailers, as collection points, interact directly with 
consumers. By integrating consumers’ purchase 
records with recycling records, they can offer 
personalized recommendations and improve quality of 
service. In some cases, retailers provide promotional 
activities, such as discount coupons, bonuses, etc. to 
improve consumers’ awareness of possibilities to 
return expired drugs. 
However, these measures provide only limited 
value for participants. Due to strict regulations and 
health and safety concerns, the impact of actual cost 
savings per returned product for waste drugs recycling 
management is small [8]. Sorting and separating 
processes for returned medicines can be complex, and 
often only a minority of products are intact, in good 
condition and in shelf life [8]. This means that the 
extent to which reuse of medicines can affordably 
reduce the costs of medicine waste is likely to be very 
small. Thus, it is crucial to find more complementary 
measures to improve the motivation of waste drugs 
recycling enterprises. More effective savings would be 
generated from improved use of drugs [15], greater 
standardization of medicine package sizes, and 
improved prescribing patterns [1], all of which would 
reduce avoidable waste in a cost-effective manner. 
 
4.3.2. Household drug management. Household drug 
management is related to consumers. Consumers can 
manage their own drugs, such as inputting drug 
information into a computerized inventory 
management system and obtaining basic instructions 
from drug booklets about classification, precautions 
and so on. However, due to the special nature of drugs, 
especially health and environmental risks associated 
with drug use, it is important that professional actors 
(e.g. pharmacists or doctors) provide effective drug use 
instruction and help. 
 
4.3.3. Medication management. Pharmacists and 
doctors adopt medication management systems to 
evaluate and intervene in patients’ medication with 
regard to treatment effectiveness and avoidance of 
adverse drug events. Thus, drug use-related 
information is an important resource for these two 
actors’ medication management. However, in the 
independent system context, this information is rare 
because it comes from external sources, such as 
manufacturers and consumers.  
 
4.4. Two-practice scenario 
 
The second scenario shows the interaction between 
any pair of practices through sharing information and 
providing service to create incentives for participants 
in these practices, as shown in Figure 4.  
 
 
Figure 4. The interaction between pairs of two 
practices 
 
4.4.1. Waste drug recycling and household drug 
management. In scenario 1, waste drug recycling only 
focuses on collection and disposal of expired drugs. 
The value of such a system is likely to be small. 
Research findings suggest that waste drugs recycling 
cannot happen unless the consumer is compliant and 
becomes involved, e.g. to return the expired/unwanted 
drugs to the collection points [36]. In waste drugs 
recycling, the role of the consumer is not only as a 
consumer of drug/medication services, but also as an 
actor to reduce unneeded drugs and to return the 
unwanted drugs. Consumers’ expectations towards 
receivers accepting these returns form an important 
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 noneconomic aspect of consumer service [37]. 
Consumers need to be educated to manage unwanted 
medication differently, e.g. to bring the drugs to a 
collection site or hazardous waste facility rather than 
dispose of medication into water or domestic waste 
systems.  
In scenario 2, through connecting household drugs 
management and waste drug collection practices, waste 
drugs recycling can provide recycling related 
information, e.g. at the collection point, reminding 
patients of a drug’s expiration date and proper ways of 
disposal, which can have a significant influence on 
increasing product returns from consumers and reduce 
recycling costs and the waste itself. Further, waste 
drugs recycling enterprises can obtain information 
about unexpired/unwanted drugs from consumers that 
further guide drug research, development, design and 
sales. 
 Consumers can be offered more effective recycling 
waste drugs service. The drugs recycling enterprises 
provide offline and online collection channels. 
Consumers can find the nearest collection point to send 
waste drugs to or order expired drugs pick-up in their 
homes online. Consumers can track the process of drug 
disposal and share drug-related information, which 
improves consumers’ trust and involvement. 
Proposition 2. The connection between waste 
drugs recycling and household drug management 
practices has a significant positive impact on reducing 
recycling costs and waste and promotes consumers’ 
involvement and trust.  
 
4.4.2. Waste drug recycling and Medication 
management. In scenario 1, for independent 
medication management it is difficult to obtain drug-
related information because the information comes 
from external sources, such as manufacturers and 
consumers. Manufacturers have the initial instruction 
regarding drug usage and consumers have experiences 
with drugs. Waste drug management produces much 
valuable information related to expired drugs. The 
information is also an important resource for 
medication management. For example, based on the 
causes of expired drugs, doctors can improve 
prescribing patterns and pharmacists can provide 
effective advice to reduce waste.  
In addition, the independent waste drug recycling 
enterprises, e.g. manufacturers, are particularly 
concerned about the practical efficacy of drugs because 
this is directly related to their pharmaceutical research, 
development and sales.   
Proposition 3. The connection between waste 
drugs management and medication management has a 
significant positive impact on improving the efficacy 
and effective use of drugs.  
 
4.4.3. Household drug management and Medication 
management. As an indispensable resource, 
consumers’ drug and drug use-related information has 
a significant influence on medication management. 
Household drugs management provides unexpired and 
expired drug information which helps pharmacists 
make more effective evaluation and give better 
medication advise. In turn, effective drug-related 
guidance, e.g. how to use, store, and dispose of the 
drugs, raises consumers’ awareness of the impact of 
drugs on the environment and their health, which 
increases the willingness of patients to return drugs and 
to reduce waste. There is a need to increase consumers’ 
loyalty for the success and sustainability of medication 
management.  
Proposition 4. The connection between household 
drug management and medication management has a 
significant positive impact on improving the effective 
use of drugs and consumers’ awareness of 
environmental and health risks associated with drug 
use. 
 
4.5. Three-practice scenario 
 
In scenario 3, a platform emerges which simplifies 
information sharing among the three practices, 
strengthens and enriches interactions among them, and 
draws in further actors (e.g., government and 
environmental protection organizations), as shown in 
Figure 5. 
 
 
 
Figure 5. The three-practice scenario 
 
In scenario 2, although the interaction between any 
pair of two practices is beneficial to each participant, 
the redundancy of information and the complexity of 
communication act as barriers for the creation of 
further connections between practices. For all 
information, each role needs to share and communicate 
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 with others separately; for example, consumers’ drug 
information is transferred to waste drug recycling and 
medication management separately. By contrast, the 
three-practice scenario opens up a space for many 
more connections as a platform emerges which also 
has the potential to pull in further actors such as 
government and environmental protection 
organizations. 
All of the participants need more and better drug-
related information to realize their own objectives. For 
“creating” residual value, reducing waste and cost, 
waste drugs recycling enterprises need to obtain drug-
related information from both household drugs and 
medication management. Correspondingly, for 
improving effective use of drugs there is a need to 
obtain more drug use-related information from 
manufacturers and consumers. Consumers’ unexpired 
and expired drugs need to be managed effectively by 
both recycling enterprises and pharmacists. Thus, it 
becomes important to create additional connective 
ways between the three practices to strengthen and 
enrich their communication and collaboration. A 
platform will emerge from pairs of connections to 
integrate redundant information and enrich interactions 
among all actors. For example, information on how to 
effectively use a drug or a class of drugs, how to 
dispose of drugs, and on drug quality certification 
could be shared among all participants. At the same 
time, information security and privacy protection 
caused by information sharing can be addressed more 
effectively. 
In addition, the three-practice scenario not only 
expands existing services and the user base but also 
increases its scope and reach by including new actors. 
For example, government can now realize a more 
effective supervision to strengthen drug safety, 
information security, and privacy protection because of 
better integration of unexpired/expired drugs 
information and medication management. Moreover, in 
recent years environmental protection organizations 
have become more concerned about expired drugs and 
their possible negative impact on soil and water 
because pharmaceutical contamination is becoming 
ubiquitous in the environment. As pharmaceutical 
contamination cannot be effectively removed from 
wastewater by conventional methods, the occurrence of 
expired drugs  has received increasing attention by  
environmental protection organization [38] 
Proposition 5.  As the number of connections 
between practices increases, a platform emerges that 
simplifies and enriches the connections between all 
three practices and thus creates even more possibilities 
for expanding existing services and the user base, 
including opportunities to increase the scope of the 
network and the range of stakeholders. 
 
5. Conclusions  
 
Our analysis and scenarios have shown that there is 
a significant potential to increase the motivation for all 
actors concerned with expired drugs recycling by 
connecting the three involved practices of waste drug 
recycling, medication management, and household 
drug management in manifold ways. From a practical 
perspective, connecting the three practices in this 
manner would greatly contribute to effectively 
addressing a growing problem and burden for the 
environment resulting from increasing usage of 
medicines by an aging and more affluent population. 
From a theoretical perspective, our analysis suggests a 
novel mechanism for information infrastructure 
emergence. While information infrastructure 
development has so far been portrayed as primarily 
driven through growth at the periphery, mostly through 
user activity enabled by modular and flexible designs, 
an information infrastructure may also emerge de novo 
as a result of connecting so far unrelated practices in a 
sufficiently rich and multi-directional manner, similar 
to the phenomenon of state transitions known from 
physics. Our scenarios show how such a ‘phase 
transition’, i.e. the phenomenon of emergence, might 
come about for the case of information infrastructures. 
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